Literature DB >> 32775518

A Complex Hyperkinetic Movement Disorder Responsive to Immunotherapy in a Patient with Neuromyelitis Optica.

Rafaela F Aguiar1, Paulo R Nóbrega1,2, Samuel Ranieri O Veras1, Fernanda M Maia3,4, Manoel A Sobreira-Neto1,2,5, Pedro Braga-Neto1,2,6.   

Abstract

Entities:  

Keywords:  movement disorders; neuromyelitis optica; pseudoathetosis

Year:  2020        PMID： 32775518      PMCID： PMC7396851          DOI： 10.1002/mdc3.12996

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  7 in total

Review 1.  Hemiballismus: current concepts and review.

Authors:  Jason S Hawley; William J Weiner
Journal:  Parkinsonism Relat Disord       Date:  2011-09-17       Impact factor: 4.891

2.  Pseudoathetosis: report of three patients.

Authors:  Mariana Spitz; Alexandre Aluízio Costa Machado; Rodrigo do Carmo Carvalho; Fernanda Martins Maia; Monica Santoro Haddad; Dagoberto Calegaro; Milberto Scaff; Egberto Reis Barbosa
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

3.  Pseudochoreoathetosis can be the first clinical manifestation of anti-Hu-neuropathy associated with squamous cell carcinoma.

Authors:  Christoph Schrader; Güldan Alwan; Karin Weissenborn
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

4.  Spinal pseudoathetosis: a rare, forgotten syndrome, with a review of old and recent descriptions.

Authors:  J Ghika; J Bogousslavsky
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

Review 5.  Vitamin B12 deficiency presenting with severe pseudoathetosis of upper limbs.

Authors:  S B Blunt; M Silva; C Kennard; R Wise
Journal:  Lancet       Date:  1994-02-26       Impact factor: 79.321

6.  Pseudochoreoathetosis. Movements associated with loss of proprioception.

Authors:  F R Sharp; T A Rando; S A Greenberg; L Brown; S M Sagar
Journal:  Arch Neurol       Date:  1994-11

7.  Neuromyelitis Optica Spectrum Disorder Presenting with Pseudoathetosis.

Authors:  Hung Youl Seok; Seong Hwa Jang; Sooyeoun You
Journal:  J Clin Neurol       Date:  2018-01       Impact factor: 3.077
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.